Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of two beclometasone/formoterol pMDI formulations on respiratory impedance in adults with asthma
2018-000353-50Phase 2Unknown
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of beclometasone dipropionate + formoterol in persistent asthma and asthma (2 arms), sponsored by Chiesi Farmaceutici S.p.A. Primary endpoint: Average AX over 60 minutes profile. Status: unknown.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
persistent asthmaasthma
Beyond the preview
Go deeper on 2018-000353-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000353-50.